Table 6.
Model | Equations |
---|---|
Model 1 | Y = 1.150 + 0.197 (p16INK4A AS) + 0.269 (Ki–67AS) |
Model 2 | Y = −0.358+ 0.267 (Ki–67AS) + 0.172 (p16INK4A P/N) + 0.570 (CortactinP/N) |
Model 3 | Y = −0.346 + 0.245 (Ki–67AS) + 0.152 (p16INK4AAS) + 0.557 (CortactinP/N) + 0.518 (RNA E6/E7 P/N) |
Model 4 | Y = 0.535 + 0.387 (Ki–67AS) + 0.142 (p16INK4A AS) + 0.530 (CortactinP/N) + 0.506 (RNA E6/E7 P/N) − 0.786 (Ki–67 P/N) |
Model 5 | Y = 0.920 + 0.387 (Ki–67 AS) + 0.139 (p16INK4A AS) + 0.539 (Cortactin P/N) + 0.517 (RNA E6/E7 P/N) − 0.747 (Ki–67 P/N) − 0.153 (Age groups) |
Note: P/N = positive or negative status, AS = Allred scored. Means of the expected values from five linear regression models in clinical pathological grades (each sample) of confirmed sample sets were shown in Supplementary Figure S5.